Drug developers, public to benefit from PH Ivermectin clinical trials 'if results are good', says DOST – Manila Bulletin
Bracing for “good results,” the Department of Science and Technology (DOST) said Thursday, Oct. 21, that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermect
Metro Manila Philippines General Aileen Wang Yolanda Robles Manila College Of Pharmacy Undersecretary For Research
Source: mb.com.ph